<DOC>
	<DOCNO>NCT00644748</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety , tolerability gabapentin treatment patient painful diabetic neuropathy . The quality life treat patient also assess .</brief_summary>
	<brief_title>A Study Efficacy Safety Gabapentin Treatment Patients With Painful Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Patients stable Diabetes Mellitus 1 2 Clinical diagnosis distal symmetric polyneuropathy minimum duration 8 week No clinically significant motor deficit Pain describe accord least one follow clinical manifestation : burning , cramp twinge , thermal mechanical alodinea Treatment medication may interfere assessment gabapentin study within 7 day adminstration gabapentin Specific systemic disease medical condition would interfere assessment gabapentin therapeutic response safety</criteria>
	<gender>All</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>